论文信息 - Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction - 字舞流文

Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction

on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, Therapies for

A. Bayés‐Genís | A. Aimo | O. Iborra-Egea

[1] E. McDonagh,et al. Open Targets Platform: supporting systematic drug–target identification and prioritisation , 2020, Nucleic Acids Res..

[2] M. Gyöngyösi,et al. CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure , 2020, European heart journal.

[3] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[4] Devin P. Sullivan,et al. A subcellular map of the human proteome , 2017, Science.

[5] I. Um,et al. Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system , 2015, Scientific Reports.